NCT05994976Recruiting
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers for Molecular Characterization of Inflammatory Skin Diseases
Source: ClinicalTrials.gov · Last updated 28 Oct 2026
Brief summary (registry, in English)
The purpose of the study is to collect different samples for molecular characterization of inflammatory skin diseases.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 9 Aug 2023
- Start date
- 17 Oct 2023
- Primary completion date
- 31 Aug 2028
- Lead sponsor
- Innovaderm Research Inc.
- Diseases
- Atopic dermatitis (eczema), Psoriasis
- NCT number
- NCT05994976
What you commit to
- Study type: Observational
- Planned participants: 500
- From 17 Oct 2023 to the primary completion date, 31 Aug 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments.
Other
- All subjects:
- Subject is a female who is pregnant or who is planning to become pregnant during the study.
Who the study is looking for
- All subjects:
- Subject is willing to participate and is capable of giving informed consent. Note: Consent must be obtained prior to any study-related procedures.
- Subject must be willing to comply with all study procedures and must be available for the duration of the study.
- Healthy volunteers:
- Male or female subject aged 18 years or older, at the time of consent.
- Subject is in good general health, according to the investigator's judgment.
- Subjects with Acne:
- Male or female subject aged 18 to 45 years old, inclusive, at the time of consent.
- Subjects with AD:
- Male or female subject aged 18 years or older, at the time of consent.
- Subject has clinically confirmed diagnosis of active AD, according to Hanifin and Rajka criteria.
- Subjects with CHE:
- Male or female subject aged 18 years or older, at the time of consent.
- Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject).
- Subjects with HS:
- Male or female subject aged 18 years or older, at the time of consent.
- Subject has a clinically confirmed diagnosis of active HS with a disease duration of ≥ 6 months before screening as determined by the investigator through subject interview and/or review of the medical history.
- Subjects with PPP:
- Male or female subject aged 18 years or older at the time of consent.
- Subject has at least a 6-month history of PPP as defined by the presence of pustules on palms and/or soles, but without evidence of infection on palms and soles (information obtained from medical chart or subject's physician, or directly from the subject).
- Subjects with psoriasis:
- Male or female subject aged 18 years or older, at the time of consent.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Innovaderm Research Inc. Coordinator of this site? Confirm its status | Montreal | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.